Eculizumab

Results: 59



#Item
11Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology

Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefi

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-03-12 23:53:04
12Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit

Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-03-12 23:53:04
13Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID[removed], 4 pages http://dx.doi.org[removed][removed]Case Report

Hindawi Publishing Corporation Case Reports in Hematology Volume 2015, Article ID[removed], 4 pages http://dx.doi.org[removed][removed]Case Report

Add to Reading List

Source URL: downloads.hindawi.com

Language: English - Date: 2015-01-29 07:03:06
14____________________________________________________________________  Pharmaceutical Benefits Advisory Committee ____________________________________________________________________  19 September 2014

____________________________________________________________________ Pharmaceutical Benefits Advisory Committee ____________________________________________________________________ 19 September 2014

Add to Reading List

Source URL: health.gov.au

Language: English - Date: 2015-04-12 10:16:35
15THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014

THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Language: English - Date: 2014-10-25 18:54:58
16THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014

THE HON PETER DUTTON MP MINISTER FOR HEALTH MINISTER FOR SPORT MEDIA RELEASE 26 October 2014

Add to Reading List

Source URL: www.cysticfibrosis.org.au

Language: English - Date: 2014-10-25 23:32:46
17Microsoft Word - LSDP submission_2014doc

Microsoft Word - LSDP submission_2014doc

Add to Reading List

Source URL: pbs.gov.au

Language: English - Date: 2015-04-10 00:39:25
18Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit

Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefit

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-13 00:39:15
19Organ failure / Immunosuppressants / Eculizumab / Kidney diseases / Hemolytic-uremic syndrome / Chronic kidney disease / Dialysis / Pharmaceutical Benefits Scheme / Kidney transplantation / Medicine / Health / Nephrology

Stakeholder meeting statement Pharmaceutical Benefits Scheme listing of eculizumab (Soliris®) for atypical haemolytic uraemic syndrome A stakeholder meeting was held on 24 June 2014 to discuss the Pharmaceutical Benefi

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-13 00:39:15
20Microsoft Word - LSDP submission_2014[removed]doc

Microsoft Word - LSDP submission_2014[removed]doc

Add to Reading List

Source URL: www.pbs.gov.au

Language: English - Date: 2015-03-04 00:09:47